---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/244323488.md"
description: "The Nasdaq Biotechnology Index rose by 1%. UroGen Pharma ADR increased by 51.92%, CureVac NV ADR rose by 37.59%, and Fortrea Holdings climbed by 15.99%. Lexeo Therapeutics fell by 9.31%, MacroGenics decreased by 9.36%, and Fate Therapeutics dropped by 9.68%"
datetime: "2025-06-12T22:07:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/244323488.md)
  - [en](https://longbridge.com/en/news/244323488.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/244323488.md)
generator: "portal-rs"
---

# 

The Nasdaq Biotechnology Index closed up 1%. Component stock UroGen Pharma ADR rose 51.92%, CureVac NV ADR increased by 37.59%, and Fortrea Holdings rose 15.99%, ranking third. Lexeo Therapeutics fell 9.31%, ranking third from the bottom, MacroGenics dropped 9.36%, and Fate Therapeutics declined 9.68%

### Related Stocks

- [CVAC.US](https://longbridge.com/en/quote/CVAC.US.md)
- [URGN.US](https://longbridge.com/en/quote/URGN.US.md)
- [LXEO.US](https://longbridge.com/en/quote/LXEO.US.md)

## Related News & Research

- [UroGen Pharma CMO Mark Schoenberg sells 60,677 common shares for $2.86 million](https://longbridge.com/en/news/296828951.md)
- [UroGen submits FDA NDA for UGN-103 bladder cancer treatment](https://longbridge.com/en/news/296102469.md)
- [Swiss National Bank Makes New $1.40 Million Investment in Urogen Pharma $URGN](https://longbridge.com/en/news/294578152.md)
- [UroGen Pharma CMO Mark Schoenberg sells 10,000 shares for $400,100](https://longbridge.com/en/news/292348759.md)
- [What UroGen Pharma (URGN)'s UGN-501 IND Clearance Means For Shareholders](https://longbridge.com/en/news/293289003.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**